2-(4-Fluorophenoxy)-N-(4-methyl-3-((4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yl)methoxy)phenyl)acetamide

Catalog No. :
ACGPLD038
CAS No. :
1111249-63-8
Molecular Formula :
C24H20FN3O4
Molecular Weight :
433.44

IUPAC Name:2-(4-fluorophenoxy)-N-(4-methyl-3-((4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yl)methoxy)phenyl)acetamide

2-(4-Fluorophenoxy)-N-(4-methyl-3-((4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yl)methoxy)phenyl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(4-Fluorophenoxy)-N-(4-methyl-3-((4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yl)methoxy)phenyl)acetamide
IUPAC Name2-(4-fluorophenoxy)-N-(4-methyl-3-((4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yl)methoxy)phenyl)acetamide
Molecular FormulaC24H20FN3O4
Molecular Weight433.44
SMILESO=C(COC1=CC=C(C=C1)F)NC2=CC=C(C(OCC(N=C3N4C=CC=C3)=CC4=O)=C2)C
InChI KeyFDJNZYWJCUBQII-UHFFFAOYSA-N
SynonymAcetamide, 2-(4-fluorophenoxy)-N-[4-methyl-3-[(4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yl)methoxy]phenyl]-
CAS No.1111249-63-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACGPLD038 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACIQTD109 route compound structure diagram
    ACIQTD109405-79-8 In Stock
  4. Then
  5. ACGPLD038 route product structure diagram
    ACGPLD0381111249-63-8
Inquiry

2. ACGPLD038 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGPLD038 route product structure diagram
    ACGPLD0381111249-63-8
Inquiry

Comments (0)